JP2007500707A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500707A5
JP2007500707A5 JP2006522027A JP2006522027A JP2007500707A5 JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5 JP 2006522027 A JP2006522027 A JP 2006522027A JP 2006522027 A JP2006522027 A JP 2006522027A JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound according
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006522027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024334 external-priority patent/WO2005012270A2/en
Publication of JP2007500707A publication Critical patent/JP2007500707A/ja
Publication of JP2007500707A5 publication Critical patent/JP2007500707A5/ja
Pending legal-status Critical Current

Links

JP2006522027A 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法 Pending JP2007500707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49085503P 2003-07-29 2003-07-29
PCT/US2004/024334 WO2005012270A2 (en) 2003-07-29 2004-07-28 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2007500707A JP2007500707A (ja) 2007-01-18
JP2007500707A5 true JP2007500707A5 (https=) 2007-09-06

Family

ID=34115440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522027A Pending JP2007500707A (ja) 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法

Country Status (4)

Country Link
US (1) US20070197541A1 (https=)
EP (1) EP1664001A2 (https=)
JP (1) JP2007500707A (https=)
WO (1) WO2005012270A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1656370B1 (en) * 2003-06-03 2012-08-15 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
ES2536001T3 (es) * 2003-07-29 2015-05-19 Melinta Therapeutics, Inc. Procedimiento para la síntesis de biariloxazolidinonas
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
AU2004309357B2 (en) * 2003-12-22 2010-10-07 Merck Sharp & Dohme Corp. Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
JP5534497B2 (ja) * 2005-06-08 2014-07-02 メリンタ セラピューティクス，インコーポレイテッド トリアゾール類の合成方法
WO2008021849A2 (en) * 2006-08-09 2008-02-21 Smithkline Beecham Corporation Novel compounds as antagonists or inverse agonists at opioid receptors
JP5466759B2 (ja) 2009-05-28 2014-04-09 ノバルティス アーゲー ネプリライシン阻害剤としての置換アミノ酪酸誘導体
SG176009A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
PL2479165T3 (pl) * 2009-09-16 2018-05-30 Astellas Pharma Inc. Związek glicynowy
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
TR201808541T4 (tr) 2013-02-14 2018-07-23 Novartis Ag Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
JP6301371B2 (ja) 2013-02-14 2018-04-11 ノバルティス アーゲー インビボ効力が改善されたｎｅｐ阻害剤としての置換ビスフェニルブタン酸誘導体
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
EP3604271A1 (en) 2013-06-28 2020-02-05 Auckland Uniservices Limited Peptides for amino acid and peptide conjugates and conjugation process
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
CN107205989A (zh) 2014-11-14 2017-09-26 梅琳塔治疗公司 治疗、预防或降低皮肤感染风险的方法
CN107250103A (zh) 2014-12-23 2017-10-13 玛格丽特·安妮·布林布尔 氨基酸缀合物和肽缀合物以及其用途
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
TW201735952A (zh) 2016-02-26 2017-10-16 瑪格蕾特 安 布萊博 胺基酸及肽共軛物以及共軛過程
US10202334B2 (en) 2016-12-09 2019-02-12 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase
KR20240136380A (ko) 2022-01-14 2024-09-13 엔코 켐 인코포레이티드 프로토포르피리노겐 산화효소 억제제
CN120794967A (zh) * 2024-04-10 2025-10-17 沈阳药科大学 联芳基噁唑烷酮类化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
TW572757B (en) * 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU5889701A (en) * 2000-06-05 2001-12-17 Dong A Pharm Co Ltd Novel oxazolidinone derivatives and a process for the preparation thereof
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1656370B1 (en) * 2003-06-03 2012-08-15 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
ES2536001T3 (es) * 2003-07-29 2015-05-19 Melinta Therapeutics, Inc. Procedimiento para la síntesis de biariloxazolidinonas

Similar Documents

Publication Publication Date Title
JP2007500707A5 (https=)
JP2007514782A5 (https=)
JP2013508297A5 (https=)
RU2005100516A (ru) Производные 2-уреидо-6-гетероарил-3н-бензимидазол-6-карбоновой кислоты и родственные соединения в качестве ингибиторов гиразы и/или топоизомеразы iv для лечения бактериальных инфекций
JP2013508299A5 (https=)
CA2513463A1 (en) Gyrase inhibitors and uses thereof
JP2013508298A5 (https=)
PE20120626A1 (es) Composiciones farmaceuticas que comprende nilotinib
JP2004502752A5 (https=)
JP2005533061A5 (https=)
RU2003121398A (ru) Ингибиторы гиразы бактерий и их применения
RU2009135067A (ru) Производные иминопиридина и их применение в качестве микробиоцидов
RU2008125055A (ru) 2-(фенил или гетероцикло)-1h-фенантро[9.10-d]имидазолы в качестве ингибиторов mpges-1
WO2008117079B1 (en) Antimicrobial compounds based upon 4-aminoquinoline
CA2631880A1 (en) Chromane substituted benzimidazoles and their use as acid pump inhibitors
JP2013535487A5 (https=)
JP2012522053A5 (https=)
JP2003516404A5 (https=)
JP2008526999A5 (https=)
DE60115465D1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
KR20060113625A (ko) 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체
JP2014513690A5 (https=)
JP2003518106A5 (https=)
RU2006100484A (ru) Соединения, обладающие ингибирующей активностью в отношении фосфатидилинозит-3-киназы, фармацевтическая композиция, способ определения эффективности этих соединений, способ лечения нарушений (варианты) и способ изменения передачи сигнала в клетках
JP2020519687A5 (https=)